EADV 2024: Wegovy shows promise in treating common, chronic skin condition
Patients with obesity and hidradenitis suppurative treated with Wegovy experienced reduced flare-ups and improved quality of life.
26 September 2024
26 September 2024
Patients with obesity and hidradenitis suppurative treated with Wegovy experienced reduced flare-ups and improved quality of life.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.